Vetoquinol SA

Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer.
Quotes
- Bid
- Ask
- Open
- Previous close
- Volume
- Relative volume
- High
- Low
Returns
Key stats
ESG risk
ESG risk is a measure of how well a company manages material ESG risks. Sustainalytics’ ESG risk category is designed to help investors identify and understand financially material ESG risks at the company level and how they might affect the long-term performance for equity investments. The scale is from 0-100. The lower the risk, the better (0 is equivalent to no risk and 100 the most severe).
Download ESG risk methodology (PDF)Financials
About Vetoquinol SA
Vetoquinol SA operates is a France-based firm serving in the healthcare market. Its focus lies on developing and marketing veterinary drugs mainly in the European region and to a certain extent in America and Asia. Its portfolio of drugs entails anti-infectives, anti- pain inflammatory drugs, cardiovascular and nephrology treatment intended mainly for pets and livestock.
Frequently asked questions
To buy Vetoquinol SA stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Vetoquinol SA by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Vetoquinol SA is VETO:xpar. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Vetoquinol SA has its primary listing on Euronext Paris. You can trade Vetoquinol SA with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Vetoquinol SA is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Vetoquinol SA as part of a broader investment portfolio.